Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Scientific Reports
|
April 18, 2023
Factor-specific generative pattern from large-scale drug-induced gene expression profile
Se Hwan Ahn, Ju Han Kim
Genes
|
April 27, 2024
Contradiction in Star-Allele Nomenclature of Pharmacogenes between Common Haplotypes and Rare Variants
Se Hwan Ahn, Yoomi Park, Ju Han Kim
Frontiers in Pharmacology
|
December 18, 2024
Pharmacogenomic profiling of the South Korean population: Insights and implications for personalized medicine
Mi Seon Youn, Se Hwan Ahn, Ju Han Kim
JACS Au
|
May 1, 2026
Enabling Synthetically Feasible Molecular Editing in Drug Discovery via Reaction-Regulated Graph-Based Genetic Algorithms
Sung Wook Moon, Se Hwan Ahn, Jin Hee Ahn, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 11, 2020
Identification of new arylsulfide derivatives as anti-melanogenic agents in a zebrafish model
Se Hwan Ahn, Kyu-Seok Hwang, Dae-Seop Shin, et al.
International Journal of Molecular Sciences
|
February 2, 2021
Neurochemical Effects of 4-(2Chloro-4-Fluorobenzyl)-3-(2-Thienyl)-1,2,4-Oxadiazol-5(4H)-One in the Pentylenetetrazole (PTZ)-Induced Epileptic Seizure Zebrafish Model
Seong Soon Kim, Hyemin Kan, Kyu-Seok Hwang, et al.
Fish & Shellfish Immunology
|
January 28, 2019
Anti-inflammatory effect of a novel synthetic compound 1-((4-fluorophenyl)thio)isoquinoline in RAW264.7 macrophages and a zebrafish model
Geum Ran Kim, Jung Yoon Yang, Kyu-Seok Hwang, et al.
Neurochemistry International
|
October 9, 2020
Efficacy and pharmacokinetics evaluation of 4-(2-chloro-4-fluorobenzyl)-3-(2-thienyl)-1,2,4-oxadiazol-5(4H)-one (GM-90432) as an anti-seizure agent
Kyu-Seok Hwang, Hyemin Kan, Seong Soon Kim, et al.
Molecules (Basel, Switzerland)
|
May 13, 2026
5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity
Kyu-Seok Hwang, Se Hwan Ahn, Yuji Son, et al.
Journal of Medicinal Chemistry
|
January 23, 2026
Development of Novel Small-Molecule Targeting SCN1A-Associated Severe Myoclonic Epilepsy of Infancy
Dong Gun Kim, Kyu-Seok Hwang, Se Hwan Ahn, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Scientific Reports
|
April 18, 2023
Factor-specific generative pattern from large-scale drug-induced gene expression profile
Se Hwan Ahn, Ju Han Kim
Genes
|
April 27, 2024
Contradiction in Star-Allele Nomenclature of Pharmacogenes between Common Haplotypes and Rare Variants
Se Hwan Ahn, Yoomi Park, Ju Han Kim
Frontiers in Pharmacology
|
December 18, 2024
Pharmacogenomic profiling of the South Korean population: Insights and implications for personalized medicine
Mi Seon Youn, Se Hwan Ahn, Ju Han Kim
JACS Au
|
May 1, 2026
Enabling Synthetically Feasible Molecular Editing in Drug Discovery via Reaction-Regulated Graph-Based Genetic Algorithms
Sung Wook Moon, Se Hwan Ahn, Jin Hee Ahn, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 11, 2020
Identification of new arylsulfide derivatives as anti-melanogenic agents in a zebrafish model
Se Hwan Ahn, Kyu-Seok Hwang, Dae-Seop Shin, et al.
International Journal of Molecular Sciences
|
February 2, 2021
Neurochemical Effects of 4-(2Chloro-4-Fluorobenzyl)-3-(2-Thienyl)-1,2,4-Oxadiazol-5(4H)-One in the Pentylenetetrazole (PTZ)-Induced Epileptic Seizure Zebrafish Model
Seong Soon Kim, Hyemin Kan, Kyu-Seok Hwang, et al.
Fish & Shellfish Immunology
|
January 28, 2019
Anti-inflammatory effect of a novel synthetic compound 1-((4-fluorophenyl)thio)isoquinoline in RAW264.7 macrophages and a zebrafish model
Geum Ran Kim, Jung Yoon Yang, Kyu-Seok Hwang, et al.
Neurochemistry International
|
October 9, 2020
Efficacy and pharmacokinetics evaluation of 4-(2-chloro-4-fluorobenzyl)-3-(2-thienyl)-1,2,4-oxadiazol-5(4H)-one (GM-90432) as an anti-seizure agent
Kyu-Seok Hwang, Hyemin Kan, Seong Soon Kim, et al.
Molecules (Basel, Switzerland)
|
May 13, 2026
5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity
Kyu-Seok Hwang, Se Hwan Ahn, Yuji Son, et al.
Journal of Medicinal Chemistry
|
January 23, 2026
Development of Novel Small-Molecule Targeting SCN1A-Associated Severe Myoclonic Epilepsy of Infancy
Dong Gun Kim, Kyu-Seok Hwang, Se Hwan Ahn, et al.
Page
of 2